Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.

NCT05864014 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

213

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-Induced Thrombocytopenia

Interventions

DRUG: Hetrombopag
DRUG: Hetrombopag plus Placebo
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.